Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Advertisements

Esophageal Adenocarcinoma
The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Extrahepatic Manifestations of HCV Infection
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Obesity Heats Up Adipose Tissue Lymphocytes
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Muscle Cramps in Cirrhosis: A Moving Target
Nathalie Adda, Doug J. Bartels, Linda Gritz, Tara L
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update  Emmet B. Keeffe, Douglas T. Dieterich,
Mauricio Garcia-Saenz-de-Sicilia, MD, Andres Duarte-Rojo, MD, MS, DSC 
Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders  Robert P. Hirten, Marietta Iacucci, Shailja Shah,
Hepatitis C-associated B-cell non-Hodgkin lymphomas
Pichamol Jirapinyo, Christopher C. Thompson 
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Coordinating Care in Patients With Cirrhosis
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Is HCV Infection a Neurologic Disorder?
Suna Yapali, Nizar Talaat, Anna S. Lok 
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies  Kally Cheung, Samuel S. Lee, Maitreyi.
Value of Autoantibody Analysis in the Differential Diagnosis of Chronic Cholestatic Liver Disease  Piotr Milkiewicz, Hayman Buwaneswaran, Catalina Coltescu,
R. Balfour Sartor, MD  Clinical Gastroenterology and Hepatology 
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Volume 134, Issue 5, Pages (May 2008)
Judy A. Trieu, Mohammad Bilal, Ali Hashmi 
Important Elements for the Diagnosis of Drug-Induced Liver Injury
Hepatitis C and Lymphoproliferative Disorders: From Mixed Cryoglobulinemia to Non- Hodgkin's Lymphoma  Lenna A. Martyak, Melina Yeganeh, Sammy Saab  Clinical.
Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis  Zobair M. Younossi  Clinical.
No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening  Brianna L. Norton,
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
Acute-on-Chronic Liver Failure, Human Serum Albumin, and Immune Modulation: The Beginning of an Exciting Adventure  Vicente Arroyo  Clinical Gastroenterology.
May Min, Jason Ferreira, Charles Wang 
Michael Charlton  Clinical Gastroenterology and Hepatology 
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection  Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.
Michel I. Kafrouni, Robert A. Anders, Sumita Verma 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C  Zobair M. Younossi,
William D. Leslie  Clinical Gastroenterology and Hepatology 
Dushyant Singh, Reetu Singh, Wendell K. Clarkston 
Effect of Human Immunodeficiency Virus and Antiretrovirals on Outcomes of Hepatitis C: A Systematic Review From an Epidemiologic Perspective  Jennifer.
David H. Bruining, William J. Sandborn 
Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis.
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update  Emmet B. Keeffe, Douglas T. Dieterich,
Brendan Campbell, Benny Liu, Taft Bhuket, Robert J. Wong 
Kamal V. Patel, Rishi M. Goel, Terry Wong 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Issue Highlights Clinical Gastroenterology and Hepatology
Alan Bonder, MD, Nezam H. Afdhal, MD 
Hepatic Cyst? Clinical Gastroenterology and Hepatology
In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009  Maria Stepanova, Alita Mishra,
Marina Somin, Nadia Sokolowski, Stephen D.H. Malnick 
Christos Konstantakis, Maria Karamesini, Christos Triantos 
Immune Dysfunction and Infections in Patients With Cirrhosis
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders  Evan S. Dellon, MD,
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Clinical Gastroenterology and Hepatology
Coagulation in Liver Disease: A Guide for the Clinician
Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism?  John S. Leeds, David S. Sanders 
Stephen A. Harrison  Clinical Gastroenterology and Hepatology 
GI Bleeding, Colon Varicosities, and Visceral Enlargement as a Manifestation of Klippel– Trenaunay Syndrome  Fnu Deepinder  Clinical Gastroenterology and.
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008  Zobair M. Younossi, Maria Stepanova,
Rintaro Hashimoto, Akimichi Chonan 
The Role of Psychosocial Care in Adapting to Health Care Reform
Presentation transcript:

Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver Ira M. Jacobson, Patrice Cacoub, Luigino Dal Maso, Stephen A. Harrison, Zobair M. Younossi  Clinical Gastroenterology and Hepatology  Volume 8, Issue 12, Pages 1017-1029 (December 2010) DOI: 10.1016/j.cgh.2010.08.026 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Possible mechanisms of mixed cryoglobulinemia vasculitis. HCV-mediated effects on lymphocytes may lead to antibody production and formation/deposition of immune complexes containing rheumatoid factor, resulting in tissue damage. IgG, immunoglobulin G. Clinical Gastroenterology and Hepatology 2010 8, 1017-1029DOI: (10.1016/j.cgh.2010.08.026) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Differential diagnosis between mixed cryoglobulinemia and other autoimmune-lymphoproliferative disorders in the setting of HCV infection. MC syndrome, primary SS, and RA show a clinicopathological overlap, including the possible association with HCV infection. Adapted with permission (Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006;18:54–63). The following parameters may be usefully employed for a correct differential classification/diagnosis: primary SS shows typical histopathological pattern of salivary gland involvement and specific autoantibodies (anti-RoSSA/LaSSB), which are rarely found in MC patients; conversely, cutaneous leukocytoclastic vasculitis, visceral organ involvement (glomerulonephritis, hepatitis), low C4, and HCV infection are typically found in MC. Moreover, erosive symmetrical polyarthritis and serum anti-CCP characterize classical RA. Finally, B-NHL may complicate these diseases, more frequently MC and SS. The appearance of B-NHL can be detected by timely and careful clinicoserological monitoring and diagnosed by bone marrow/lymph node biopsies and total body CT scan. Anti-CCP, anti-cyclic citrullinated peptide antibodies; B-NHL, B-cell NHL; RF, rheumatoid factor; SS, Sjögren's syndrome. Clinical Gastroenterology and Hepatology 2010 8, 1017-1029DOI: (10.1016/j.cgh.2010.08.026) Copyright © 2010 AGA Institute Terms and Conditions

Figure 3 Possible mechanisms of lymphoma development include growth stimulation via BLys ligand-receptor activity, progression from MC to lymphoma via an oncogenic event, and direct and indirect lymphocyte transformation. AID, activation-induced deaminase; BCR, B cell receptor; NOS, nitric oxide synthase. Clinical Gastroenterology and Hepatology 2010 8, 1017-1029DOI: (10.1016/j.cgh.2010.08.026) Copyright © 2010 AGA Institute Terms and Conditions

Figure 4 Possible mechanisms of insulin resistance include effects of HCV-induced fibrosis/cirrhosis, direct viral effects on insulin sensitivity via proinflammatory cytokines, and effects of obesity in the development of insulin signalling defects. Clinical Gastroenterology and Hepatology 2010 8, 1017-1029DOI: (10.1016/j.cgh.2010.08.026) Copyright © 2010 AGA Institute Terms and Conditions